Strategic funding PercuSense has secured targeted grants and government contracts that validate its CGKM biosensor technology and provide credible case studies for adoption by defense and healthcare procurement teams.

Defense opportunity A multiyear contract with the U.S. Department of Defense demonstrates interest from national security sectors in continuous monitoring biosensors, signaling a potential entry point for expanded government-facing procurement and compliance conversations.

Integrated monitoring The multi-analyte continuous sensor platform positions PercuSense to cross-sell to hospitals, clinics, and remote monitoring programs seeking comprehensive biosensor solutions rather than single-parameter devices.

Small-to-mid market fit With 11-50 employees and a revenue range of 1M-10M, PercuSense appears agile for partnerships with mid-market health systems, medtech distributors, and contract manufacturers seeking innovative, scalable sensor technology.

Strategic partnerships Recent funding and customer wins suggest opportunities to partner with healthcare and defense-focused integrators, research institutions, and grant-driven initiatives to accelerate deployment and validation of continuous monitoring solutions.